NCT05339919

Brief Summary

By tracking the short-term and long-term results of patients after hepatectomy, the difference of short-term results between patients with sarcopenia and patients without sarcopenia was analyzed, and the correlation between sarcopenia and short-term and long-term results of patients after hepatectomy was explored, so as to improve people's awareness of sarcopenia and pay attention to its prevention and treatment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 11, 2021

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

April 9, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 21, 2022

Completed
3.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 28, 2025

Completed
Last Updated

June 15, 2022

Status Verified

June 1, 2022

Enrollment Period

1.3 years

First QC Date

April 9, 2022

Last Update Submit

June 14, 2022

Conditions

Keywords

SarcopeniaLiver cancerHepatectomyShort-term outcomesLong-term outcomes

Outcome Measures

Primary Outcomes (2)

  • Short-term postoperative results

    Postoperative complications;90 days readmission rate

    3 months

  • Long-term results after operation

    Overall survival; Disease free survival

    10 years

Secondary Outcomes (2)

  • Postoperative hospitalization time

    2 months

  • Hospitalization expenses

    2 months

Interventions

The chair stand test was administered, and the time required for the patient to stand five times from a sitting position without using the arms was measured. CT scan was to scan the patient's third lumbar level. For the gait speed test, the time that patients spent walking 8 meters on a flat indoor floor at usual walking speed was measured.Grip strength test:the dominant hand and the nondominant hand were measured twice intermittently (kg), and the average value of 4 values was obtained.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with preoperative clinical diagnosis of liver cancer admitted to the hepatobiliary surgery department and received standard tests and questionnaires.

You may qualify if:

  • Patients with preoperative clinical diagnosis of liver cancer
  • No cancer other than liver cancer has been diagnosed
  • Age ≥18 years

You may not qualify if:

  • Patients who could not complete the standard tests and questionnaires
  • Patients who did not accept liver resection after evaluation of treatment plan
  • Patients who had other concomitant preoperative causes of muscle weakness (injury, fracture, stroke, etc.)
  • Patients who missing CT data or CT scan did not reach the level of the third lumbar vertebra (L3)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gang Chen

Wenzhou, Zhejiang, 325000, China

Location

Biospecimen

Retention: SAMPLES WITH DNA

night soil;whole blood;Tissue specimen

MeSH Terms

Conditions

Liver NeoplasmsSarcopenia

Interventions

Walking Speed

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesLiver DiseasesMuscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Intervention Hierarchy (Ancestors)

GaitPhysical ExaminationDiagnostic Techniques and ProceduresDiagnosisWalkingLocomotionMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Gang Chen, M.D.

    First Affiliated Hospital of Wenzhou Medical University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor, Principal Investigator

Study Record Dates

First Submitted

April 9, 2022

First Posted

April 21, 2022

Study Start

May 1, 2020

Primary Completion

August 11, 2021

Study Completion

August 28, 2025

Last Updated

June 15, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

Locations